Literature DB >> 15312133

Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.

P Han1, T McDonald, G Hodge.   

Abstract

There are reports of immaturity of the neonatal immune system, which may explain the low incidence of graft-versus-host-disease (GVHD) after cord blood transplantation. The CD40 ligand (CD40L)-CD40 interaction is important in regulating the cellular immune response. We hypothesized that the neonatal immune system may show immaturity in this interaction. We studied the function of the CD40L-CD40 interaction in the T-cell interaction with B cells and monocytes in cord blood compared with adult blood in vitro. Consistent with previous reports, CD4+ T cells do not express CD40L after T-cell activation. In whole blood, adult monocytes, but not neonatal monocytes, were activated following T-cell activation. However, the activation of adult monocytes was not dependent on the CD40L-CD40 interaction. Using the CD40L trimer (Lt), we showed that cord B cells have comparable responses to CD40 ligation to those of the adult B cells. Both cord and adult monocytes do not respond as well as B cells and this is probably related to low density of expression of CD40. However, interferon-gamma up-regulated CD40 on adult monocytes but not on cord monocytes. This potentiated the adult monocyte response to CD40 ligation by CD40Lt. Our findings suggest that the neonatal CD40L-CD40 pair is immature in the cellular immune response involving monocytes and that interferon-gamma fails to activate neonatal monocytes for a response to CD40L. These findings suggest that in the inflammatory microenvironment of cord blood transplantation neonatal monocytes may play a minor role in the effector arm of the immune response. This finding may be one of several mechanisms for the low incidence of GVHD that is observed following cord blood transplantation. Also the ligand-receptor immaturity may contribute to the increased susceptibility of newborns to certain infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312133      PMCID: PMC1782544          DOI: 10.1111/j.1365-2567.2004.01933.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Impaired interferon-alpha enhancement of neonatal monocyte phagocytosis.

Authors:  A E el-Mohandes; D S Brudno; M D Ahronovich
Journal:  Biol Neonate       Date:  1990

Review 2.  The role of CD40 and its ligand in the regulation of the immune response.

Authors:  D Hollenbaugh; H D Ochs; R J Noelle; J A Ledbetter; A Aruffo
Journal:  Immunol Rev       Date:  1994-04       Impact factor: 12.988

Review 3.  T-cell regulation of macrophage function.

Authors:  T M Doherty
Journal:  Curr Opin Immunol       Date:  1995-06       Impact factor: 7.486

4.  Cord blood B cells are mature in their capacity to switch to IgE-producing cells in response to interleukin-4 in vitro.

Authors:  G Pastorelli; F Rousset; J Pène; C Peronne; M G Roncarolo; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 5.  The role of the CD28 receptor during T cell responses to antigen.

Authors:  P S Linsley; J A Ledbetter
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

6.  CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation.

Authors:  P Lane; C Burdet; F McConnell; A Lanzavecchia; E Padovan
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

7.  Diminished expression of CD40 ligand by activated neonatal T cells.

Authors:  S Nonoyama; L A Penix; C P Edwards; D B Lewis; S Ito; A Aruffo; C B Wilson; H D Ochs
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.

Authors:  A Durandy; G De Saint Basile; B Lisowska-Grospierre; J F Gauchat; M Forveille; R A Kroczek; J Y Bonnefoy; A Fischer
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

9.  Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.

Authors:  F H Durie; A Aruffo; J Ledbetter; K M Crassi; W R Green; L D Fast; R J Noelle
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.

Authors:  V A Boussiotis; G J Freeman; G Gray; J Gribben; L M Nadler
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  11 in total

1.  Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 receptor complex in human neonatal B cells.

Authors:  Cuixia Tian; Grace K Kron; Kevin M Dischert; James N Higginbotham; James E Crowe
Journal:  Immunology       Date:  2006-06-08       Impact factor: 7.397

Review 2.  Defective antigen-presenting cell function in human neonates.

Authors:  Paula A Velilla; Maria T Rugeles; Claire A Chougnet
Journal:  Clin Immunol       Date:  2006-09-28       Impact factor: 3.969

Review 3.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

4.  Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function.

Authors:  Cesar M Rueda; Maria E Moreno-Fernandez; Courtney M Jackson; Suhas G Kallapur; Alan H Jobe; Claire A Chougnet
Journal:  Eur J Immunol       Date:  2015-06-25       Impact factor: 5.532

Review 5.  Dissecting the defects in the neonatal CD8+ T-cell response.

Authors:  Adam J Fike; Ogan K Kumova; Alison J Carey
Journal:  J Leukoc Biol       Date:  2019-07-01       Impact factor: 4.962

Review 6.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

7.  Maturation of innate responses to mycobacteria over the first nine months of life.

Authors:  Muki S Shey; Elisa Nemes; Wendy Whatney; Marwou de Kock; Hadn Africa; Charlene Barnard; Michele van Rooyen; Lynnett Stone; Catherine Riou; Tobias Kollmann; Thomas R Hawn; Thomas J Scriba; Willem A Hanekom
Journal:  J Immunol       Date:  2014-04-14       Impact factor: 5.422

Review 8.  Challenges in vaccination of neonates, infants and young children.

Authors:  Michael E Pichichero
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

9.  Is Infant Immunity Actively Suppressed or Immature?

Authors:  Ana L Gervassi; Helen Horton
Journal:  Virology (Auckl)       Date:  2014

10.  Whole Blood Profiling of Bacillus Calmette-Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation.

Authors:  Steven G Smith; Johanneke Kleinnijenhuis; Mihai G Netea; Hazel M Dockrell
Journal:  Front Immunol       Date:  2017-06-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.